Edition:
United Kingdom

PerkinElmer Inc (PKI.N)

PKI.N on New York Stock Exchange

75.57USD
6:18pm BST
Change (% chg)

$-0.78 (-1.02%)
Prev Close
$76.35
Open
$76.34
Day's High
$76.35
Day's Low
$75.57
Volume
17,382
Avg. Vol
166,249
52-wk High
$84.42
52-wk Low
$62.43

Chart for

About

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food,... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $7,782.25
Shares Outstanding(Mil.): 110.21
Dividend: 0.07
Yield (%): 0.40

Financials

  PKI.N Industry Sector
P/E (TTM): 37.86 148.43 32.74
EPS (TTM): 1.87 -- --
ROI: 5.38 9.37 14.38
ROE: 9.09 14.69 16.08

UPDATE 1-PerkinElmer raises 2018 forecasts as 1st-qtr profit beats Street

April 30 Laboratory equipment maker PerkinElmer posted a slightly higher-than-expected first-quarter profit on Monday and revised its full-year earnings forecast upward as sales grew in both of its business units.

30 Apr 2018

PerkinElmer first-quarter profit beats Street view

April 30 Laboratory equipment maker PerkinElmer on Monday reported slightly higher-than-expected first-quarter profit and revenue and raised its full-year earnings forecast as sales grew in both of its business units.

30 Apr 2018

BRIEF-PerkinElmer Appoints James Mock As Chief Financial Officer

* PERKINELMER INC - ANDY WILSON WILL REMAIN WITH COMPANY AS AN ADVISOR FOR AN INTERIM PERIOD Source text for Eikon: Further company coverage:

10 Apr 2018

BRIEF-PerkinElmer Collaborates With Helix In Exome Based Personal Genomics

* PERKINELMER COLLABORATES WITH HELIX TO DRIVE INNOVATION IN EXOME-BASED PERSONAL GENOMICS

10 Apr 2018

BRIEF-Perkinelmer Inc Files Prospectus Supplement Related To A Potential Senior Notes Offering‍​

* PERKINELMER INC FILES PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL SENIOR NOTES OFFERING - SEC FILING‍​‍​ Source text: (https://bit.ly/2q3PNq6) Further company coverage:

04 Apr 2018

BRIEF-Perkinelmer - CEO Robert Friel's 2017 Total Compensation Was $11.4 Mln

* PERKINELMER INC - CEO ROBERT FRIEL'S 2017 TOTAL COMPENSATION WAS $11.4 MILLION VERSUS $9.5 MLN‍​ Source text: (http://bit.ly/2tUAUen) Further company coverage:

14 Mar 2018

BRIEF-RHS Enters Deal For Perkinelmer, Inc To Buy All Shares Of Co For $0.28 Per Share

* ENTERS SCHEME IMPLEMENTATION AGREEMENT FOR PERKINELMER, INC TO BUY ALL SHARES OF CO FOR $0.28 PER SHARE

25 Feb 2018

BRIEF-Perkinelmer Reports‍​ Q4 GAAP Loss Per Share From Cont Ops of $0.35

* Q4 ADJUSTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS $0.97

25 Jan 2018

PerkinElmer profit, 2018 forecast top Wall Street estimates

Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.

25 Jan 2018

UPDATE 1-PerkinElmer profit, 2018 forecast top Wall Street estimates

Jan 25 Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.

25 Jan 2018

Competitors

Earnings vs. Estimates